| [1] |
Redman CW, Sargent IL. Latest advances in understanding preeclampsia[J]. Science, 2005, 308(5728):1592-1594.
|
| [2] |
Mahande MJ, Daltveit AK, Mmbaga BT, et al. Recurrence of preeclampsia in northern Tanzania: a registry-based cohort study[J]. PLoS One, 2013, 8(11):e79116.
|
| [3] |
Bramham K, Briley AL, Seed P, et al. Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study[J]. Am J Obstet Gynecol, 2011, 204(6):511-512.
|
| [4] |
Dildy GA, Belfort MA, Smulian JC. Preeclampsia Recurrence and Prevention[J]. Semin Perinatol, 2007, 31(3):135-141.
|
| [5] |
Wong TY, Groen H, Faas MM, et al. Clinical risk factors for gestational hypertensive disorders in pregnant women at high risk for developing preeclampsia[J]. Pregnancy Hypertens, 2013, 3(4):248-253.
|
| [6] |
Li XL, Chen TT, Dong X, et al. Early onset preeclampsia in subsequent pregnancies correlates with early onset preeclampsia in first pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 177:94-99.
|
| [7] |
Mostello D, Kallogjeri D, Tungsiripat R, et al. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births[J]. Am J Obstet Gynecol, 2008, 199(1):51-55.
|
| [8] |
Mostello D, Jen Chang J, Allen J, et al. Recurrent preeclampsia the effect of weight change between pregnancies[J]. Obstet Gynecol, 2010, 116(3):667-672.
|
| [9] |
Hnat MD, Sibai BM, Caritis S, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas[J]. Am J Obstet Gynecol, 2002, 186(3):422-426.
|
| [10] |
Harutyunyan A, Armenian H, Petrosyan V. Interbirth interval and history of previous preeclampsia: a case-control study among multiparous women[J]. BMC Pregnancy Childbirth, 2013, 13:244.
|
| [11] |
Trogstad LI, Eskild A, Magnus P, et al. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 54728 women with and without previous pre-eclampsia[J]. Int J Epidemiol, 2001, 30(6):1317-1322.
|
| [12] |
Basso O, Christensen K, Olsen J. Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals？[J]. Epidemiology, 2001, 12(6):624-629.
|
| [13] |
Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy[J]. Am J Epidemiol, 2000, 151(1):57-62.
|
| [14] |
Rodger MA. Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy[J]. Thromb Res, 2009, 123 Suppl 2:S100-S104.
|
| [15] |
Rodger MA, Paidas M, Mclintock C, et al. Inherited thrombophilia and pregnancy complications revisited[J]. Obstet Gynecol, 2008, 112(2 Pt 1):320-324.
|
| [16] |
Rath W. Pre-eclampsia and inherited thrombophilia: a reappraisal[J]. Semin Thromb Hemost, 2011, 37(2):118-124.
|
| [17] |
Facchinetti F, Marozio L, Frusca T, et al. Maternal thrombophilia and the risk of recurrence of preeclampsia[J]. Am J Obstet Gynecol, 2009, 200(1):41-46.
|
| [18] |
Kupferminc MJ, Rimon E, Many A, et al. Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications[J]. J Matern Fetal Neonatal Med, 2011, 24(8):1042-1045.
|
| [19] |
van Rijn BB, Hoeks LB, Bots ML, et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia[J]. Am J Obstet Gynecol, 2006, 195(3):723-728.
|
| [20] |
Rasmussen S, Irgens LM. History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension[J]. Hypertension, 2008, 51(4):1231-1238.
|
| [21] |
Rasmussen S, Irgens LM, Albrechtsen S, et al. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy[J]. Obstet Gynecol, 2000, 96(5 Pt 1):696-700.
|
| [22] |
Aviram R, T BS, Kidron D. Placental aetiologies of foetal growth restriction: clinical and pathological differences[J]. Early Hum Dev, 2010, 86(1):59-63.
|
| [23] |
Trogstad L, Skrondal A, Stoltenberg C, et al. Recurrence risk of preeclampsia in twin and singleton pregnancies[J]. Am J Med Genet A, 2004, 126A(1):41-45.
|
| [24] |
Sibai BM, Koch MA, Freire S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension[J]. Am J Obstet Gynecol, 2011, 204(4):341-345.
|
| [25] |
Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study[J]. Lancet, 2006, 368(9542):1164-1170.
|
| [26] |
Sohlberg S, Stephansson O, Cnattingius S, et al. Maternal body mass index, height, and risks of preeclampsia[J]. Am J Hypertens，2012, 25(1):120-125.
|
| [27] |
Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy[J]. Cochrane Database Syst Rev, 2014, 2:D2252.
|
| [28] |
Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[J]. Cochrane Database Syst Rev, 2007, (2):CD004659.
|
| [29] |
Coomarasamy A, Honest H, Papaioannou S, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review[J]. Obstet Gynecol, 2003, 101(6):1319-1332.
|
| [30] |
Redman CW. Hypertension in pregnancy: the NICE guidelines[J]. Heart, 2011, 97(23):1967-1969.
|
| [31] |
Rossi AC, Mullin PM. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 158(1):9-16.
|
| [32] |
Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary[J]. BJOG, 2007, 114(8):933-943.
|
| [33] |
Patrelli TS, Dall′Asta A, Gizzo S, et al. Calcium supplementation and prevention of preeclampsia: a meta-analysis[J]. J Matern Fetal Neonatal Med, 2012, 25(12):2570-2574.
|
| [34] |
Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial[J]. Lancet, 2006, 367(9517):1145-1154.
|
| [35] |
Conde-Agudelo A, Romero R, Kusanovic JP, et al. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2011, 204(6):501-503.
|
| [36] |
Villar J, Purwar M, Merialdi M, et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries[J]. BJOG, 2009, 116(6):780-788.
|
| [37] |
American Congress of Obstetric and Gynecologists. Hypertetion in pregnancy[J]. Obstet Gynecol, 2013, 122:1122-1131.
|
| [38] |
Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team[J]. BJOG, 2000, 107(3):382-395.
|
| [39] |
Olafsdottir AS, Skuladottir GV, Thorsdottir I, et al. Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy[J]. BJOG, 2006, 113(3):301-309.
|
| [40] |
de Vries JI, van Pampus MG, Hague WM, et al. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT[J]. J Thromb Haemost, 2012, 10(1):64-72.
|
| [41] |
Mello G, Parretti E, Fatini C, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women[J]. Hypertension, 2005, 45(1):86-91.
|
| [42] |
Kupferminc M, Rimon E, Many A, et al. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia[J]. Blood Coagul Fibrinolysis, 2011, 22(2):123-126.
|